Ir al contenido
· Skin boosters
SKU 11122

Aquashine HA

En stock
Volumen
1 x 2 mL
Laboratorio
Caregen Co., Ltd.
Origen
Corea del Sur
Indicación
Skin hydration, revitalization and age-related correction
Zonas de tratamiento
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.
Etiquetas

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Principales ventajas de Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Información clave
Marca AQUASHINE
Fabricante Caregen Co., Ltd.
País de origen South Korea
Certificación CE marked (per MDD 93/42/EEC)
Composición Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
Volumen / Tamaño 2 ml
Envase 1 x 2 mL
Tamaño de la aguja 30G (0.30 x 13 mm)
Tipo de uso For professional use - intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
Profundidad de inyección Middle and superficial dermis
Protocolo / Duración Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

Indicaciones y uso profesional

Indicaciones principales

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

Uso profesional

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

Zonas de tratamiento

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

Perfil del paciente

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

Cómo funciona Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Por qué comprar en Allpara

Allpara ofrece productos AQUASHINE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

/ Especificaciones

La ficha técnica

Categoría
Skin boosters
Marca
AQUASHINE
Laboratorio
Caregen Co., Ltd.
SKU
11122
Formato
1 x 2 mL
Origen
Corea del Sur
Indicación
Skin hydration, revitalization and age-related correction
Uso
Professional injectable biorevitalization treatment
Zonas de tratamiento
/ Detalles del producto

El expediente completo

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Caregen Co., Ltd., país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

What is in Aquashine HA?
Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).
Where is Aquashine HA injected?
Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.
How does Aquashine HA differ from Aquashine HA BR?
Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.
/ FAQ

Preguntas frecuentes

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).
Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.
Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

Más productos de Caregen

Ver laboratorio

Alternativas para la clínica

Todos los productos

Aquashine HA

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Principales ventajas de Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Información clave
Marca AQUASHINE
Fabricante Caregen Co., Ltd.
País de origen South Korea
Certificación CE marked (per MDD 93/42/EEC)
Composición Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
Volumen / Tamaño 2 ml
Envase 1 x 2 mL
Tamaño de la aguja 30G (0.30 x 13 mm)
Tipo de uso For professional use - intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
Profundidad de inyección Middle and superficial dermis
Protocolo / Duración Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

Indicaciones y uso profesional

Indicaciones principales

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

Uso profesional

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

Zonas de tratamiento

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

Perfil del paciente

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

Cómo funciona Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Por qué comprar en Allpara

Allpara ofrece productos AQUASHINE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

Más productos de Caregen

Ver el laboratorio →

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Caregen Co., Ltd., país de origen Corea del Sur.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.